Skip to main content
TipRanks
Go Ultimate75% OFF

Y-Biologics Inc. (338840) Stock Price & Analysis

338840 Stock Chart & Stats

₩8,900.00-₩270.00(-2.94%)
At close: 3:30 PM GMT+9
₩7.5K₩10KAug 18Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
KRW 8,650.00 - KRW 9,190.00
52-Week Range
KRW 6,330.00 - KRW 38,000.00
Previous Close
KRW 9,170.00
Volume
N/A
Average Volume (3M)
71.38K
Market Cap
KRW 141.25B
Enterprise Value
KRW 162.87B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
0.54
Next Earnings
Nov 13, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

338840 FAQ

What was Y-Biologics Inc.’s price range in the past 12 months?
Y-Biologics Inc. lowest stock price was ₩6330.00 and its highest was ₩38000.00 in the past 12 months.
What is Y-Biologics Inc.’s market cap?
Y-Biologics Inc.’s market cap is ₩141.25B.
When is Y-Biologics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Y-Biologics Inc.’s earnings last quarter?
Y-Biologics Inc. released its earnings results on Aug 14, 2026. The company reported -₩510 earnings per share for the quarter.
Is Y-Biologics Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Y-Biologics Inc. pay dividends?
Y-Biologics Inc. does not currently pay dividends.
What is Y-Biologics Inc.’s EPS estimate?
Y-Biologics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Y-Biologics Inc. have?
Y-Biologics Inc. has 15,403,863 shares outstanding.
What happened to Y-Biologics Inc.’s price movement after its last earnings report?
Y-Biologics Inc. reported an EPS of -₩510 in its last earnings report. Following the earnings report the stock price went down -4.926%.
Which hedge fund is a major shareholder of Y-Biologics Inc.?
Currently, no hedge funds are holding shares in KR:338840
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology